Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
Santosh Suryavanshi, Igor Kovalchuk, Olga Kovalchuk
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation
Dalia M. Kopustinskienė, Rūta Masteiková, Robertas Lažauskas, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 660-660
Open Access | Times Cited: 74
Molecular and Cellular Mechanisms of Action of Cannabidiol
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5980-5980
Open Access | Times Cited: 45
Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
Christos C. Zouboulis, Tom Coenye, Li He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
Xinxin Xiong, Siyu Chen, Jianfei Shen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro
Santosh Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1391-1391
Open Access | Times Cited: 45
Microglia in neuroimmunopharmacology and drug addiction
Hongyuan Li, Linda R. Watkins, Xiaohui Wang
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1912-1924
Closed Access | Times Cited: 9
The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 8
Cannabinoids as Potential Multitargeting Neuroprotectants in Neuropathic Pain: Exploring the Interplay between Cannabinoid System and Autophagy
Heba‐Tallah Abd Elrahim Abd Elkader, Sara El Idrissi, Sana Sellami, et al.
IntechOpen eBooks (2025)
Closed Access
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access
The Link between Cannabis Use, Immune System, and Viral Infections
Sanjay B. Maggirwar, Jag H. Khalsa
Viruses (2021) Vol. 13, Iss. 6, pp. 1099-1099
Open Access | Times Cited: 43
Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
Marcin Janecki, Michał Graczyk, Agata Anna Lewandowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4170-4170
Open Access | Times Cited: 26
Inflammation and cancer: friend or foe?
Andrés David Turizo-Smith, Samantha Córdoba-Hernandez, Lidy Vannessa Mejía-Guarnizo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
José Alexandre S. Crippa, Júlia Cozar Pacheco, Antônio Waldo Zuardi, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 658-669
Open Access | Times Cited: 34
A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
Robert L. Chapman, Shridhar V. Andurkar
Medicinal Chemistry Research (2021) Vol. 31, Iss. 1, pp. 40-51
Open Access | Times Cited: 31
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
Liliang Li, Pan Gao, Xinru Tang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1
Adriana Yndart, Nagesh Kolishetti, Arti Vashist, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Microglia NLRP3 Inflammasome and Neuroimmune Signaling in Substance Use Disorders
Ming‐Lei Guo, Soheil Kazemi Roodsari, Yan Cheng, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 922-922
Open Access | Times Cited: 11
Phytochemical Analysis of the Methanolic Extract and Essential Oil from Leaves of Industrial Hemp Futura 75 Cultivar: Isolation of a New Cannabinoid Derivative and Biological Profile Using Computational Approaches
Simona De Vita, Claudia Finamore, Maria Giovanna Chini, et al.
Plants (2022) Vol. 11, Iss. 13, pp. 1671-1671
Open Access | Times Cited: 20
Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
Alissa Michel, Richard Lee, Elahe Salehi, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 10
Cannabinoids and neuroinflammation: Therapeutic implications
Brian E. Leonard, Feyza Arıcıoğlu
Journal of Affective Disorders Reports (2023) Vol. 12, pp. 100463-100463
Open Access | Times Cited: 9
Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)
Alexander Thomson, Taralyn M. McCarrel, Alexander Zakharov, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 2
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signalling and TYK2-Mediated STAT3 Signalling Pathways <em>In Vitro</em>
Santosh Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, et al.
(2022)
Open Access | Times Cited: 13
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
Alice Hartmann dos Santos, Carla Vila-Verde, Francisco Silveira Guimarães, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 284-308
Open Access | Times Cited: 10
Measles vaccination – An underestimated prevention measure: Analyzing a fatal case in Hildesheim, Germany
Katharina Hueppe, Jan Ortman, Hannah Gauselmann, et al.
International Journal of Medical Microbiology (2024) Vol. 314, pp. 151608-151608
Open Access | Times Cited: 1
Melanoma and cannabinoids: A possible chance for cancer treatment
Mariarosaria Galeano, Federico Vaccaro, Natasha Irrera, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 7
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top